Discontinuation of reimbursement of benzodiazepines in the Netherlands: does it make a difference?

BACKGROUND: In an attempt to control chronic benzodiazepine use and its costs in the Netherlands, health care insurance reimbursement of this medication was stopped on January 1(st) 2009. This study investigates whether benzodiazepine prescriptions issued by general practitioners changed during the...

Descripción completa

Detalles Bibliográficos
Autores principales: Kollen, Boudewijn J, van der Veen, Willem Jan, Groenhof, Feikje, Donker, Gé A, van der Meer, Klaas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534512/
https://www.ncbi.nlm.nih.gov/pubmed/23170874
http://dx.doi.org/10.1186/1471-2296-13-111

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3534512/
https://www.ncbi.nlm.nih.gov/pubmed/23170874
http://dx.doi.org/10.1186/1471-2296-13-111

Ejemplares similares